APPROVED
 FOR PMR

KEVZARA is indicated for the treatment of adults with polymyalgia rheumatica (PMR) after corticosteroids have been used and did not work well or when a slow decrease in the dose of corticosteroids (taper) cannot be tolerated

Approval Press Release    

Download the Brochure    

APPROVED
 FOR PMR

KEVZARA is indicated for the treatment of adults with polymyalgia rheumatica (PMR) after corticosteroids have been used and did not work well or when a slow decrease in the dose of corticosteroids (taper) cannot be tolerated

Approval Press Release    

Download the Brochure    

Get helpful tools, tips and resources

Enter your name to receive additional tools, tips, and resources you’ll find helpful.





You may have certain rights under applicable data privacy laws regarding the personal information that you provide, including the right to withdraw consent from future collection or sharing of your information. For further information regarding these rights, please reference Sanofi US Privacy Policies and Consumer Health Data Privacy Policy.